The affordable medicines facility-malaria - A success in peril

No Thumbnail Available

Date

2012

Journal Title

Journal ISSN

Volume Title

Publisher

Malaria Journal

Abstract

The Affordable Medicines Facility-malaria (AMFm) has put into place a bold financing plan for artemisinin-combination therapy in a pilot phase in seven countries covering half the population at risk of malaria in Africa. A report of the AMFm independent evaluation, conducted by ICF International and the London School of Hygiene and Tropical Medicine, describes the success of the programme in the pilot sites: Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania (mainland and Zanzibar) and Uganda, comparing availability and affordability of high-quality artemisinin-combination therapies before and after AMFm launched. Proof of concept was achieved: AMFm increased availability and kept prices low, meeting its initial, ambitious benchmarks in most settings. Despite this overwhelming success, opposition to the programme and dwindling resources for malaria control conspire to cripple or kill AMFm.

Description

Keywords

Malaria/economics, Malaria/treatment, AMFm, ACT, Global fund

Citation

Talisuna, A. O., Adibaku, S., Amojah, C. N., Amofah, G. K., Aubyn, V., Dodoo, A., . . . Shija, S. J. (2012). The affordable medicines facility-malaria - A success in peril. Malaria Journal, 11. Link for full text: http://www.malariajournal.com/content/pdf/1475-2875-11-370.pdf

Endorsement

Review

Supplemented By

Referenced By